Sanofi lands EC approval for its cholesterol-busting Praluent
Permalink

Sanofi lands EC approval for its cholesterol-busting Praluent

Investors in healthcare giants Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi (NYSE:SNY) were given another reason to…

Continue Reading →